Evidence map›Paper›PMID 36224622›Full record

ArticleBMC veterinary research2022

Detection of SARS-CoV-2 in a dog with hemorrhagic diarrhea.

Miguel Padilla-Blanco, Santiago Vega, Luis Enjuanes, Alfonso Morey, Teresa Lorenzo, Clara Marín, Carmen Ivorra, Elisa Maiques, Vicente Rubio, Consuelo Rubio-Guerri

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC veterinary research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Miguel Padilla-BlancoDepartamento de Farmacia, Facultad de Ciencias de la Salud, Universidad Cardenal Herrera-CEU, 46113, Alfara del Patriarca, Valencia, Spain.
Santiago VegaDepartamento de Producción y Sanidad Animal, Salud Pública Veterinaria y Ciencia y Tecnología de los Alimentos, Instituto de Ciencias Biomédicas, Facultad de Veterinaria, Universidad Cardenal Herrera-CEU, 46115, Alfara del Patriarca, Valencia, Spain. svega@uchceu.es.
Luis EnjuanesCentro Nacional de Biotecnología (CNB-CSIC), Campus de Cantoblanco, Universidad Autónoma de Madrid, 28049, Madrid, Spain.
Alfonso MoreyClínica Veterinaria Morey, 51004, Ceuta, Spain.
Teresa LorenzoDepartamento de Ciencias Biomédicas, Facultad de Ciencias de la Salud, Universidad Cardenal Herrera-CEU, Alfara del Patriarca, 46113, Madrid, Spain.
Clara MarínDepartamento de Producción y Sanidad Animal, Salud Pública Veterinaria y Ciencia y Tecnología de los Alimentos, Instituto de Ciencias Biomédicas, Facultad de Veterinaria, Universidad Cardenal Herrera-CEU, 46115, Alfara del Patriarca, Valencia, Spain.
Carmen IvorraI+D+I Department, Sequencing Multiplex SL (I+D+I, Seqplexing), Parque Científico Universidad de Valencia, 46980, Paterna, Valencia, Spain.
Elisa MaiquesDepartamento de Ciencias Biomédicas, Facultad de Ciencias de la Salud, Universidad Cardenal Herrera-CEU, Alfara del Patriarca, 46113, Madrid, Spain.
Vicente RubioInstituto de Biomedicina de Valencia del Consejo Superior de Investigaciones Científicas (IBV-CSIC) and CIBERER-ISCIII, 46010, Valencia, Valencia, Spain. rubio@ibv.csic.es.
Consuelo Rubio-GuerriDepartamento de Farmacia, Facultad de Ciencias de la Salud, Universidad Cardenal Herrera-CEU, 46113, Alfara del Patriarca, Valencia, Spain. consuelo.rubio@uchceu.es.ORCID http://orcid.org/0000-0001-9001-0437
Universidad Cardenal Herrera CEU · ESCentro Nacional de Biotecnología · ESClínica Rementería · ESConsejo Superior de Investigaciones Científicas · ESUniversitat de València · ES

Funding

Agencia Estatal de Investigación PID2020-120322RB-C21Agencia valenciana de innovación COVID-19-203Generalitat Valenciana GV/2021/163
6 · The paper itself

Abstract

backgroundSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, has infected several animal species, including dogs, presumably via human-to-animal transmission. Most infected dogs reported were asymptomatic, with low viral loads. However, in this case we detected SARS-CoV-2 in a dog from the North African coastal Spanish city of Ceuta presenting hemorrhagic diarrhea, a disease also reported earlier on in an infected dog from the USA. CASE PRESENTATION: In early January 2021, a West Highland Terrier pet dog from Ceuta (Spain) presented hemorrhagic diarrhea with negative tests for candidate microbial pathogens. Since the animal was in a household whose members suffered SARS-CoV-2 in December 2020, dog feces were analyzed for SARS-CoV-2, proving positive in a two-tube RT-PCR test, with confirmation by sequencing a 399-nucleotide region of the spike (S) gene. Furthermore, next-generation sequencing (NGS) covered > 90% SARS-CoV-2 genome sequence, allowing to classify it as variant B.1.177. Remarkably, the sequence revealed the Ile402Val substitution in the spike protein (S), of potential concern because it mapped in the receptor binding domain (RBD) that mediates virus interaction with the cell. NGS reads mapping to bacterial genomes showed that the dog fecal microbiome fitted best the characteristic microbiome of dog's acute hemorrhagic diarrhea.

conclusionOur findings exemplify dog infection stemming from the human SARS-CoV-2 pandemic, providing nearly complete-genome sequencing of the virus, which is recognized as belonging to the B.1.177 variant, adding knowledge on variant circulation in a geographic region and period for which there was little viral variant characterization. A single amino acid substitution found in the S protein that could have been of concern is excluded to belong to this category given its rarity and intrinsic nature. The dog's pathology suggests that SARS-CoV-2 could affect the gastrointestinal tract of the dog.

Indexed as

COVID-19Dog DiseasesAnimalsDiarrheaDogsHumansNucleotidesSARS-CoV-2Spike Glycoprotein, CoronavirusNucleotidesSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2B.1.177Dog COVID-19Ile402Val S protein substitutionOne HealthSARS-CoV-2Zoonosis

Identifiers

PMID36224622
PMCPMC9554378
OpenAlexW4304789669

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.